We present 14 patients with secondary gluacoma following the implantation of a posterior chamber intraocular lens (lOLs). All patients were u-nilateral gluacoma , which developed within 1 month following the IOL impla...We present 14 patients with secondary gluacoma following the implantation of a posterior chamber intraocular lens (lOLs). All patients were u-nilateral gluacoma , which developed within 1 month following the IOL implantation in 10 cases, and from 1 to 3 years in 4 cases. The angle of anterior chamber was open in 8 patients, and close in 6 ones. Seven patients required treatment of antiglaucomatous medicine; 4 patients underwent laser indecto-my and 3 patients required antiglaucoma surgery. The results s...展开更多
AIM: To determine the incidence and risk factors of secondary glaucoma after pediatric cataract surgery.METHODS: Two hundred and forty nine eyes of 148 patients underwent cataract surgery without intraocular lens (IOL...AIM: To determine the incidence and risk factors of secondary glaucoma after pediatric cataract surgery.METHODS: Two hundred and forty nine eyes of 148 patients underwent cataract surgery without intraocular lens (IOL) implantation (group 1), and 220 eyes of 129 patients underwent cataract surgery with IOL implantation (group 2) retrospectively, were evaluated between 2000 and 2011. The outcome measure was the presence or absence of post-cataract surgery glaucoma, defined as an intraocular pressure (IOP) ≥26mmHg, as measured on at least two occasions along with corneal or optic nerve changes.RESULTS: The mean follow-up periods of group 1 and 2 were (60.86 ±30.95) months (12-123 months) and (62.11±31.29) months (14-115 months) respectively. In group 1, 12 eyes of 8 patients (4.8% ) developed glaucoma. None of the patients developed glaucoma after surgery in group 2. The mean age of the patients at the cataract surgery was (2.58±0.90) months (1 month-4 months) and the average period for glaucoma development after surgery was (9.50 ±4.33) months (4-16 months) in group 1. Three of the 12 glaucomatous eyes were controlled with antiglaucomatous medication and 9 eyes underwent trabeculectomy+mitomycinC surgery.Onepatientunderwent a second trabeculectomy+mitomycin C operation for both of his eyes.CONCLUSION:The incidence of glaucoma after pediatric cataract surgery is very low in patients in whom IOL is implanted. The aphakic eyes after pediatric cataract surgery are at an increased risk for glaucoma development particularly if they underwent surgery before 4 months of age.展开更多
AIM:To report outcomes of patients after intraocular lens(IOL)repositioning or exchange for the version of the uveitisglaucoma-hyphema(UGH)syndrome that does not include closed loop anterior chamber IOL(nUGH).METHODS:...AIM:To report outcomes of patients after intraocular lens(IOL)repositioning or exchange for the version of the uveitisglaucoma-hyphema(UGH)syndrome that does not include closed loop anterior chamber IOL(nUGH).METHODS:Chart review of patients with nUGH who underwent IOL repositioning or exchange by one surgeon were reviewed.The main outcome measures were best corrected visual acuity(BCVA)as a decimal fraction preoperatively and postoperatively after IOL repositioning or exchange.Clinical findings evaluated included the presence of uveitis,hyphema,elevated intraocular pressure(IOP),and other complications such as pigment dispersion or vitreous hemorrhage.The number of anti-inflammatory and glaucoma medications were assessed before and after IOL repositioning or exchange.RESULTS:The study included 14 pseudophakic eyes.The median time at the onset of contemporary UGH after cataract extraction and IOL implantation(CE/IOL)was7.5 y.IOL repositioning or exchange was performed at a mean duration of 8.1±4.7 mo(median:4 mo)after onset of UGH.The mean BCVA was improved from 0.45±0.26 preoperatively after onset of UGH syndrome to 0.76±0.22(P=0.016)after IOL repositioning or exchange.Among the14 eyes,uveitis,elevated IOP,and hyphema were present preoperatively in 13,13,and 6 eyes,respectively.Uveitis and hyphema resolved in all cases after IOL surgery.The mean IOP was reduced from 26.4±4.5 mm Hg preoperatively to 14.7±4.9 postoperatively(P=0.01).The mean number of glaucoma medications used was reduced from 1.7±1.1 medications preoperatively to 0.8±1.08(P=0.04)postoperatively.CONCLUSION:IOL repositioning or exchange is an effective treatment in many cases for medically resistant contemporary UGH syndrome.展开更多
目的观察白内障并发闭眼角型青光眼患者的临床治疗工作现状,分析行Phaco、人工晶体植入联合小梁切除术治疗的临床效果及术后并发症情况。方法借助统计软件将2018年1月至2019年12月期间在枣庄市薛城区人民医院眼科接受手术治疗的70例白...目的观察白内障并发闭眼角型青光眼患者的临床治疗工作现状,分析行Phaco、人工晶体植入联合小梁切除术治疗的临床效果及术后并发症情况。方法借助统计软件将2018年1月至2019年12月期间在枣庄市薛城区人民医院眼科接受手术治疗的70例白内障并发闭眼角型青光眼患者分为两组,对照组接受Phaco、人工晶体植入术治疗,研究组接受Phaco、人工晶体植入联合小梁切除术治疗,两组患者对比手术前后视力情况、眼内压力、超声生物显微镜指标、手术治疗效果及术后并发症情况。结果两组患者手术前视力[(4.52±0.11)比(4.50±0.13)]、眼压[(37.09±3.81)mmHg比(37.05±3.83)mmHg,1 mmHg=0.133 kPa]比较差异均无统计学意义(均P>0.05);研究组患者手术后视力提升情况高于对照组[(4.99±0.43)比(4.60±0.54)](P<0.05),而眼压低于对照组[(11.52±1.42)mmHg比(25.66±1.21)mmHg](P<0.05);两组患者手术前超声生物显微镜指标比较差异均无统计学意义(均P>0.05),研究组患者手术后30 d ACD、TIA、TCPD指标数值均高于对照组(均P<0.05),而AOD500指标数值低于对照组(P<0.05);研究组患者手术疗效评价高于对照组[97.14%(34/35)比68.87%(24/35)],而术后并发症发生率低于对照组[2.86%(1/35)比37.14%(13/35)],两组比较差异有统计学意义(P<0.05)。结论白内障并发闭眼角型青光眼患者接受Phaco、人工晶体植入、小梁切除术三联治疗,可有效改善视力、眼压及房角结果,减少术后并发症率,提高手术疗效,该三联治疗方式在临床上具有较高应用价值。展开更多
文摘We present 14 patients with secondary gluacoma following the implantation of a posterior chamber intraocular lens (lOLs). All patients were u-nilateral gluacoma , which developed within 1 month following the IOL implantation in 10 cases, and from 1 to 3 years in 4 cases. The angle of anterior chamber was open in 8 patients, and close in 6 ones. Seven patients required treatment of antiglaucomatous medicine; 4 patients underwent laser indecto-my and 3 patients required antiglaucoma surgery. The results s...
文摘AIM: To determine the incidence and risk factors of secondary glaucoma after pediatric cataract surgery.METHODS: Two hundred and forty nine eyes of 148 patients underwent cataract surgery without intraocular lens (IOL) implantation (group 1), and 220 eyes of 129 patients underwent cataract surgery with IOL implantation (group 2) retrospectively, were evaluated between 2000 and 2011. The outcome measure was the presence or absence of post-cataract surgery glaucoma, defined as an intraocular pressure (IOP) ≥26mmHg, as measured on at least two occasions along with corneal or optic nerve changes.RESULTS: The mean follow-up periods of group 1 and 2 were (60.86 ±30.95) months (12-123 months) and (62.11±31.29) months (14-115 months) respectively. In group 1, 12 eyes of 8 patients (4.8% ) developed glaucoma. None of the patients developed glaucoma after surgery in group 2. The mean age of the patients at the cataract surgery was (2.58±0.90) months (1 month-4 months) and the average period for glaucoma development after surgery was (9.50 ±4.33) months (4-16 months) in group 1. Three of the 12 glaucomatous eyes were controlled with antiglaucomatous medication and 9 eyes underwent trabeculectomy+mitomycinC surgery.Onepatientunderwent a second trabeculectomy+mitomycin C operation for both of his eyes.CONCLUSION:The incidence of glaucoma after pediatric cataract surgery is very low in patients in whom IOL is implanted. The aphakic eyes after pediatric cataract surgery are at an increased risk for glaucoma development particularly if they underwent surgery before 4 months of age.
基金The Bascom Palmer Eye Institute is supported by NIH Center Core(No.P30EY014801)a Research to Prevent Blindness Unrestricted GrantLee RK is supported by the Walter G.Ross Foundation。
文摘AIM:To report outcomes of patients after intraocular lens(IOL)repositioning or exchange for the version of the uveitisglaucoma-hyphema(UGH)syndrome that does not include closed loop anterior chamber IOL(nUGH).METHODS:Chart review of patients with nUGH who underwent IOL repositioning or exchange by one surgeon were reviewed.The main outcome measures were best corrected visual acuity(BCVA)as a decimal fraction preoperatively and postoperatively after IOL repositioning or exchange.Clinical findings evaluated included the presence of uveitis,hyphema,elevated intraocular pressure(IOP),and other complications such as pigment dispersion or vitreous hemorrhage.The number of anti-inflammatory and glaucoma medications were assessed before and after IOL repositioning or exchange.RESULTS:The study included 14 pseudophakic eyes.The median time at the onset of contemporary UGH after cataract extraction and IOL implantation(CE/IOL)was7.5 y.IOL repositioning or exchange was performed at a mean duration of 8.1±4.7 mo(median:4 mo)after onset of UGH.The mean BCVA was improved from 0.45±0.26 preoperatively after onset of UGH syndrome to 0.76±0.22(P=0.016)after IOL repositioning or exchange.Among the14 eyes,uveitis,elevated IOP,and hyphema were present preoperatively in 13,13,and 6 eyes,respectively.Uveitis and hyphema resolved in all cases after IOL surgery.The mean IOP was reduced from 26.4±4.5 mm Hg preoperatively to 14.7±4.9 postoperatively(P=0.01).The mean number of glaucoma medications used was reduced from 1.7±1.1 medications preoperatively to 0.8±1.08(P=0.04)postoperatively.CONCLUSION:IOL repositioning or exchange is an effective treatment in many cases for medically resistant contemporary UGH syndrome.
文摘目的观察白内障并发闭眼角型青光眼患者的临床治疗工作现状,分析行Phaco、人工晶体植入联合小梁切除术治疗的临床效果及术后并发症情况。方法借助统计软件将2018年1月至2019年12月期间在枣庄市薛城区人民医院眼科接受手术治疗的70例白内障并发闭眼角型青光眼患者分为两组,对照组接受Phaco、人工晶体植入术治疗,研究组接受Phaco、人工晶体植入联合小梁切除术治疗,两组患者对比手术前后视力情况、眼内压力、超声生物显微镜指标、手术治疗效果及术后并发症情况。结果两组患者手术前视力[(4.52±0.11)比(4.50±0.13)]、眼压[(37.09±3.81)mmHg比(37.05±3.83)mmHg,1 mmHg=0.133 kPa]比较差异均无统计学意义(均P>0.05);研究组患者手术后视力提升情况高于对照组[(4.99±0.43)比(4.60±0.54)](P<0.05),而眼压低于对照组[(11.52±1.42)mmHg比(25.66±1.21)mmHg](P<0.05);两组患者手术前超声生物显微镜指标比较差异均无统计学意义(均P>0.05),研究组患者手术后30 d ACD、TIA、TCPD指标数值均高于对照组(均P<0.05),而AOD500指标数值低于对照组(P<0.05);研究组患者手术疗效评价高于对照组[97.14%(34/35)比68.87%(24/35)],而术后并发症发生率低于对照组[2.86%(1/35)比37.14%(13/35)],两组比较差异有统计学意义(P<0.05)。结论白内障并发闭眼角型青光眼患者接受Phaco、人工晶体植入、小梁切除术三联治疗,可有效改善视力、眼压及房角结果,减少术后并发症率,提高手术疗效,该三联治疗方式在临床上具有较高应用价值。
